Lhasa Limited were thrilled to sponsor and exhibit a virtual booth at Scientific Update’s online N-nitrosamines Mini Event. Chair of AstraZeneca’s Impurity Advisory Board, Andrew Teasdale PhD spoke within the workshop, his talk was titled “N-Nitrosamines – Current status of regulations and science”.
Lhasa Principal Application Scientist, Fernanda Waechter also be presented ‘How can nitrosamine risk assessments be supported by in silico systems and data sharing initiatives?’.